Workflow
NHTSA Opens Probe Into 174K Tesla Model Y SUVs After Reports Of Children Trapped Inside: 'A Child May Not Be Able To…' - Tesla (NASDAQ:TSLA)
Benzinga· 2025-09-17 04:20
The National Highway Traffic Safety Administration (NHTSA) has opened an investigation into an estimated 174,290 Tesla Inc. TSLA Model Y crossover SUVs over faulty electronic door handles.Check out the current price of TSLA stock here.Parents Had To Break Windows To Regain Entry, NHTSA SaysThe investigation, opened on Monday after the agency said it received multiple complaints that owners of the 2021 Model Y were unable to regain access to the vehicle after exiting. The owners also complained that they wer ...
Ben & Jerry's co-founder resigns citing loss of independence under Unilever
Reuters· 2025-09-17 04:12
Ben & Jerry's co-founder Jerry Greenfield, whose name helped shape the popular ice cream brand, has quit the company, his partner Ben Cohen said on Wednesday, deepening the rift with parent Unilever. ...
Global Markets See Mixed Signals: Thailand’s Streak Ends, Japan’s Yields Shift, and Vietnam Prepares for IPO
Stock Market News· 2025-09-17 04:08
Key TakeawaysFitch Ratings has affirmed ANZ Bank New Zealand's (ANZBY) Long-Term Foreign- and Local-Currency Issuer Default Ratings (IDRs) at 'A+' with a Stable Outlook, reflecting strong support prospects from its Australian parent and a robust operating environment.Thailand's stock index concluded an eight-day winning streak, experiencing a slight decline to 1,306.46.Japanese Government Bond (JGB) yields saw notable movement, with the 5-year yield falling by 0.5 basis points to 1.15%, while a ¥614.9 billi ...
Bristol Myers to sell 60% stake in China joint venture
Reuters· 2025-09-17 04:04
Core Viewpoint - U.S. drugmaker Bristol Myers Squibb has signed an agreement to sell its 60% ownership stake in a pharmaceutical joint venture in China [1] Company Summary - Bristol Myers Squibb is divesting its majority stake in a joint venture, indicating a strategic shift in its operations in the Chinese market [1] Industry Summary - The sale reflects ongoing trends in the pharmaceutical industry where companies are reassessing their international partnerships and market presence, particularly in rapidly evolving markets like China [1]
Urban Company Share Price & IPO Listing Live: Shares listing today, GMP signals bumper debut
BusinessLine· 2025-09-17 04:03
Urban Company Stocks Today, Urban Company IPO listing & share price live updates: Shares of Urban Company Ltd debut on bourses today. The most oversubscribed Rs 1,900-cr IPO received 103.63 times subscription on the last day of bidding.Listing date and price: September 17. Lists at Rs 162.25 on the NSE and at Rs 161 on the BSEIssue size: Rs 472 crore through sale new shares, and Rs 1,428 crore from sale of stakes by existing investors.Price Band: Rs 98-103Anchor portion: Rs 854 croreUse of funds: The compan ...
Morning brief: Fed rate cut expectations, Utah seeks death penalty in Kirk killing, Baidu soars 15%
Invezz· 2025-09-17 04:02
Wednesday's top headlines spotlight major economic, political, and tech developments. Investors await a key Federal Reserve interest rate decision that could signal a policy shift, while Utah prosecut... ...
DXC Launches Global AI Center of Competence to Accelerate Enterprise AI Adoption
Prnewswire· 2025-09-17 04:01
Core Insights - DXC Technology has launched a new AI Center of Competence in Warsaw, Poland, expanding its global network of AI centers [1][2] - The center employs 500 data and AI experts who assist companies in leveraging AI for innovation, operational efficiency, and cost reduction [2][3] - Ferrovial, a global infrastructure company, is collaborating with DXC to develop the AI Workbench platform, enhancing its operational management and safety standards [2][3] Company Strategy - The AI Center of Competence focuses on three strategic pillars: resilient cloud infrastructure, intuitive AI interfaces, and a centralized hub for Research & Development [3] - The center aims to create a global ecosystem for continuous learning, collaboration, and innovation, ensuring that AI solutions are practical and impactful [4] - DXC's global AI network includes centers in Bulgaria, India, the Philippines, and Spain, reinforcing its leadership in enterprise-scale AI and data modernization [4] Customer Impact - Ferrovial is utilizing the AI Workbench to optimize decision-making and improve safety through real-time operational management [3] - The collaboration with DXC allows Ferrovial to leverage over 30 intelligent agents for swift responses to changing conditions and regulations [3] - DXC's solutions empower customers to integrate responsible AI into their operations rapidly, driving efficiency and growth across various industries [4]
Altima Completes Red Earth Property Acquisition and Provides August Workover and Production Results
Newsfile· 2025-09-17 04:00
Core Viewpoint - Altima Energy Inc. has successfully completed the acquisition of the Red Earth Property for CAD $1,050,000, enhancing its production capabilities and operational efficiency [1][3]. Group 1: Acquisition and Production - The Red Earth Acquisition is strategically located near Altima's existing assets, allowing for seamless integration and operational synergies [1]. - Following the acquisition, the company has commenced production from its collective assets, producing 5,126 barrels of oil (818 m³) in August [3]. Group 2: Workover Program - In August, Altima advanced its workover program, which successfully recommenced production in existing facilities and individual wells, leading to increased output and reduced operating costs [2][3]. Group 3: Financial Reporting - The company is in the process of completing its audited annual financial statements and related disclosures for the year ended February 28, 2025, but has faced delays due to technical issues [4]. - As a result of these delays, a cease trade order remains in effect, suspending trading in the company's securities [4]. Group 4: Company Overview - Altima Energy is focused on oil and gas exploration and production, aiming to unlock hydrocarbon asset potential across North America while maintaining a disciplined approach to asset management [5].
Hepsor AS Group company Hepsor Jugla SIA signed a construction contract for the Zaļā Jugla residential development project
Globenewswire· 2025-09-17 04:00
Core Insights - Hepsor Jugla SIA has signed a construction contract valued at 8.2 million euros for the first phase of the Zaļā Jugla residential development project in Riga [1] - The first phase will include two apartment buildings with a total of 70 new homes and a sellable area of 4,262 m², expected to be completed by Q2 2027 [2] - The entire Zaļā Jugla project will consist of three apartment buildings totaling 105 homes and a sellable area of 6,393 m², with a total estimated cost of 15 million euros for both phases [3] Company Overview - Hepsor AS is a developer of residential and commercial real estate operating in Estonia, Latvia, and Canada, having completed 2,076 homes and nearly 36,300 m of commercial space over 14 years [5] - The company has implemented innovative engineering solutions to enhance energy efficiency in its buildings, contributing to environmental sustainability [5] - Hepsor has completed a total of 404 homes in Latvia, with 96% sold, and anticipates completing over 500 new homes in the coming years [4]
Three WuXi Biologics Manufacturing Facilities Receive GMP Certification from Türkiye İlaç ve Tibbi Cihaz Kurumu (TITCK)
Prnewswire· 2025-09-17 04:00
Core Insights - WuXi Biologics has received GMP certification from Türkiye ilaç ve Tıbbi Cihaz Kurumu (TITCK) for three of its manufacturing facilities in Wuxi, marking the first GMP inspection by Turkey's TITCK at the company [1][2] - The certification reflects WuXi Biologics' commitment to maintaining high international quality standards across its global operations [1][4] Manufacturing and Quality Standards - The three facilities, MFG1, MFG2, and DP5, successfully passed a five-day onsite inspection for two monoclonal antibody biologics, validating the company's capabilities in delivering high-quality services [2] - WuXi Biologics has a strong track record, having passed 44 regulatory inspections, including 22 by the FDA and EMA, and holds a 100% pass rate for Pre-License Inspection by the FDA [3] Operational Capacity - The company operates 16 GMP-certified drug substance and drug product facilities globally, reinforcing its reputation for quality and compliance [3] - As of June 30, 2025, WuXi Biologics is supporting 864 integrated client projects, including 24 in commercial manufacturing [6] Leadership and Future Outlook - Dr. Chris Chen, CEO of WuXi Biologics, emphasized the importance of quality in ensuring safety and efficacy in the pharmaceutical industry and expressed commitment to maintaining high standards [4] - The company aims to leverage its first-class quality system and service capabilities to support clients in delivering high-quality biologics to patients worldwide [4] Sustainability Initiatives - WuXi Biologics prioritizes sustainability as a key component of long-term growth, focusing on green technology innovations and responsible practices [7]